Biomarkers and immunology

The Biomarkers and Immunology working group aims to identify immunological or brain damage-related biomarkers that relate to the development or severity of neuropsychiatric symptoms of COVID-19.

Leads

Members

Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)